Probiotics for the Treatment of Docetaxel-Related Weight Gain of Breast Cancer Patients—A Single-Center, Randomized, Double-Blind, and Placebo-Controlled Trial

Background: Docetaxel is an important chemotherapy-agent for breast cancer treatment. One of its side-effects is weight gain, which increases the all-cause mortality rate. Considering gut microbiota is one important factor for weight regulation, we hypothesized that probiotics could be potentially u...

Descripción completa

Detalles Bibliográficos
Autores principales: Juan, Zhang, Qing, Zhang, Yongping, Liang, Qian, Liyuan, Wu, Wei, Wen, Yanguang, Tong, Jianbin, Ding, Boni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675585/
https://www.ncbi.nlm.nih.gov/pubmed/34926547
http://dx.doi.org/10.3389/fnut.2021.762929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675585/
https://www.ncbi.nlm.nih.gov/pubmed/34926547
http://dx.doi.org/10.3389/fnut.2021.762929

Ejemplares similares